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Background: small diameter vascular grafts are limited by their restricted availability, early thrombosis, and requirement
for anticoagulants.
Objective: to evaluate different approaches to biocompatible vascular grafts.
Methods: sixteen allogeneic acellularised arteries seeded with autologous endothelial cells were implanted to replace a
segment of the common carotid artery (group I). Other animals received polydioxanone prostheses (group II: inner
diameter, i.d. 4 mm, n=18; group III, i.d. 5 mm, n=20) or arterial autografts (group IV, n=8). Graft patency was
evaluated by means of ultrasound duplex scanning, angiography and histology.
Results: patency was 54% (71%), 17% (0%), 50% (50%), and 100% (100%) in group I, II, III, and IV after 1 week (4
months), respectively. Significant differences (p<0.05) were found for group IV versus all other groups at 1 week, as well
as for group IV versus groups II and III, for group II versus III, and group I versus II at 4 months.
Conclusion: small diameter vascular grafts can be engineered from an acellular allogeneic matrix seeded with autologous
cells. Patency is superior to polydioxanone prostheses but inferior to the arterial autograft.
Key Words: Biocompatible; Blood vessel; Cell matrix; Cell seeding; Endothelial cells; PDS; Polydioxanone; Small calibre
vascular graft; Tissue engineering; Vascular prosthesis.
Introduction scaffolds4,12–18 and the implantation, without pre-
seeding, of biodegradable polymers such as poly-
Small calibre vascular grafts (inner diameter <4 mm) galactin9,10 or polydioxanone (PDS).19
The aim of this study was to compare biodegradableare required in coronary and in peripheral artery
bypass surgery.1,2 Currently autologous grafts and PDS prostheses and endothelial cell seeded de-
cellularised allogeneic matrix grafts with arterial auto-prostheses are limited by their restricted availability,
early thrombosis, neointimal hyperplasia, the inability grafts in vivo.
to grow, long-term aneurysm formation and the re-
quirement for anticoagulant therapy. Synthetic grafts
made of polyester or polytetrafluoroethylene (PTFE)
Materials and Methodswere developed.5 The patency of small calibre pros-
thetic grafts remains unacceptable in comparison to
Laboratory animals and anaesthesiaautologous vein or arterial grafts.3–6 More recently,
coating procedures7,8 and seeding of the bioreactive
German landrace pigs were obtained from a localsurface with endothelial9 or precursor cells10 have been
breeder (Tierzuchtanstalt Mariensee, Germany). Allevaluated with primary results.11
animals received care in compliance with the “Prin-Other approaches include the transplantation of
ciples of Laboratory Animal care” formulated by theautologous cells onto biodegradable or biological
National Society for Medical Research and the “Guide
for the Care and Use of Laboratory Animals” prepared
by the National Academy of Sciences and published
Please address all correspondence to: O. E. Teebken, Division of by the National Institute of Health. Animals wereThoracic & Cardiovascular Surgery, Hannover Medical School, Carl-
Neuberg-Str 1, D-30625 Hannover, Germany. anaesthetised with pentobarbital (30 to 40 mg/kg)
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intravenously, intubated, and mechanically ventilated PBS without Ca2+ and Mg2+. They were subcultivated
in 175 cm2 culture flasks. Endothelial cells fromwith air and isoflurane under the supervision of a
veterinary anaesthetist. the second or third passage were used for seeding
procedures. Cells were identified by their typical
morphological features in culture and by immuno-
histochemistry. In a parallel experiment, we were able
Preparation of decellularised carotid arteries to demonstrate nitric oxide synthase activity in cul-
tured endothelial cells. Nitric oxide is crucial for a
Explanted carotid arteries were immediately stored in normal vascular physiology.16
Hank’s balanced salt solution (HBSS, Biochrom, Berlin, For seeding procedures endothelial cells were tryp-
Germany) at 4 °C. Within 30 min, the vessels were sinised, centrifuged and washed, and a seeding density
placed in a solution of 0.1% trypsin (Biochrom) with of approximately 2×105 cells per cm2 was adjusted. A
0.02% EDTA (Sigma) in phosphate buffered saline 4-cm segment of a decellularised carotid artery was
(PBS, Biochrom) without Ca2+ and Mg2+ for 24 h. This filled with cell suspension and clamped at both ends.
procedure was followed by incubation with RNAse After 60 min of incubation (5% CO2/95% air at-
A (20 g/ml; Boehringer Mannheim, Germany) and mosphere at 37 °C) the vessels were gently rinsed with
DNAse (0.2 mg/ml; Boehringer Mannheim) for 2 h, culture medium and specimen for light and electron
and another incubation in 0.1% trypsin with 0.02% microscopic studies of cell attachment were taken. The
EDTA in PBS (without Ca2+ and Mg2+) for 24 h. All grafts were stored in culture medium at 37 °C and
steps were conducted in a 5% CO2/95% air atmosphere implanted within 40 min.
at 37 °C under continuous shaking. Vessels were
washed and stored in HBSS at 4 °C prior to further
processing. Samples were taken before and after en-
zymatic treatment. Implantation of arterial conduits
Both common carotid arteries were dissected over a
length of 5 cm. A segment of 2 cm length was removed
Cell isolation, expansion, and seeding after systemic heparinisation (300 Iu/kg) and proximal
and distal clamping of the carotid artery. The same
The external jugular vein was explanted approximately segment was either re-implanted (group IV, controls;
prior to implantation of seeded grafts (group I) and n=8), replaced by a seeded decellularised graft (group
stored in heparinised (Heparin Novo, Nordisk, pre- I; n=16) or replaced by a prosthesis of adequate
servative-free, Mainz, Germany) blood at 4 °C. Seg- length. Prostheses were made of woven PDS (Ethicon,
ments were filled with 0.2% collagenase A (Boehringer Hamburg, Germany) with an inner diameter of either
Mannheim) in PBS with Ca2+ and Mg2+. With both 4 mm (group II; n=18) or 5 mm (group III; n=10),
ends occluded, the vein was placed in a Petri dish depending on the native vessel’s size. Anastomoses
filled with HBSS and incubated in a 5% CO2/95% air were performed with 7-0 PDS running sutures
atmosphere at 37 °C for 20 min. Afterwards the vein (Ethicon). All animals received antibiotics (cephalexin,
was flushed with 50 ml M-199 medium with L-glu- 1200 mg/day) and analgesics (buprenorphin hydro-
tamine (Biochrom) containing 10% fetal bovine serum chloride, 0.9 mg/day) for 4 days postoperatively. No
(FBS, Life Technologies, Germany). After cen- anticoagulants or antiplatelets were administered post-
trifugation for 5 min at 300 g, endothelial cells were operatively.
resuspended in 5 ml culture medium A consisting of
M-199, 10% FBS, 100 u/ml penicillin (Sigma, St. Louis,
MO, U.S.A.), 50 g endothelial cell growth factor
(Boehringer Mannheim), and 5000 u/ml heparin. Follow-up, angiography, and histology
Finally they were placed in a 75 cm2 culture flask
(Corning Costar Corporation, Cambridge, MA, Graft patency was determined by duplex ultrasound
(Sonos 5500, Hewlett Packard, Palo Alto, CA, U.S.A.)U.S.A.), precoated with fibronectin (Sigma, 10 g/ml
in M-199) with a resulting density of 10 000 cells/cm2. using a 4 MHz probe directly postoperatively and after
1 week as well as by intra arterial digital subtractionDuring cell culture, medium was changed every
second or third day. Just before monolayers were angiography (Philips, The Netherlands) via the com-
mon femoral artery prior to sacrificing the animal.grown to confluency, the cells were detached with
0.05% trypsin (Biochrom) and 0.02% EDTA (Sigma) in Examination was performed by manual injection of
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diluted nonionic angiographic dye (iopromidium, fluorescent dyes, ethidium homodimer-1 (EthD-1), and
calcein AM (Molecular Probes, Eugene, OR, U.S.A.),Ultravist, Schering, Berlin; dilution 1:1 with 0.9% so-
diumchloride solution, Braun, Melsungen). The pat- at room temperature to distinguish live and dead cells,
simultaneously.22 Optical filters were purchased fromency was graded from normal (<20% stenosis), stenosis
([20% stenosis), and obstruction ([90% stenosis). Molecular probes.
Animals were sacrificed either 1 week or 4 months
after implantation (anaesthesia see above). Arterial
conduits were explanted and histologic sections were
Statistical analysisobtained.
Continuous variables are expressed as mean plus or
minus one standard deviation. Differences betweenScanning electron microscopy
investigations (patency) were evaluated by means of
the non-parametric Mann–Whitney test. A p<0.05 wasSpecimens were fixed by immersion in glutaraldehyde
considered significant. SPSS 10.0 for Windows was(2.5%, in 0.1 mol/l cacodylate buffer, pH 7.4) for 4 h
used.immediately after removal of the culture medium. All
specimens were postfixed with 2% osmium tetroxide
in the same buffer for 2 h, dehydrated in graded alcohol
solutions, and critical point dried over CO2. They were Results
made conductive by progressive osmium im-
pregnation in a vacuum evaporator (Ion Tech Ltd., Sixty-two carotid artery segments were replaced in 32
Teddington, U.K.) according to Kelley et al.20 Finally, pigs. Two animals in group I were grafted with only
they were coated with gold-palladium and examined) one prosthesis due to intraoperative haemodynamic
(Philips 505 microscope, XL29, 25 kV, Kassel, instability. Cross clamping times ranged from 7 to
Germany). 18 min. The other animals had an uneventful intra-
and postoperative course. Body weight increased from
33 kg±2 kg at the time of graft implantation to
Light microscopy 35 kg±1 kg (after 1 week) and 115±11 kg (after 4
months), respectively.
Samples were stored in liquid nitrogen. Semi-thin
sections were stained with haematoxylin-eosin with Duplex and angiography findings (Table 1, Fig. 1)
or subjected to an elastin stain. At the time of wound closure all grafts were patent
as shown by duplex ultrasound scanning. Patency was
54% (71%), 17% (0%), 50% (50%), and 100% (100%)
Immunohistochemistry in group I, II, III, and IV after 1 week (4 months),
respectively. Significant differences (p<0.05) were
Endothelial cells were characterised by immuno- found for group IV versus all other groups at 1 week,
histochemical staining (avidin-biotin-peroxidase-tech- as well as for group IV versus groups II and III, for
nique) of cyto spins or frozen sections for the presence group II versus III, and group I versus II at 4 months.
of factor VIII-related antigen (DAKO, Hamburg, Ger-
many) as described previously.21 Antibodies for actin
staining to mark myofibroblasts, for collagen IV and
Macroscopic findings and histological examinationfor laminin were purchased from Sigma. A goat anti-
mouse antibody (DAKO) served as secondary anti-
Acellular matrixbody. Streptavidine-peroxidase-conjugate was applied
Cell nuclei or intracellular components were not foundand final staining was done with diaminobenzidine
in hematoxylin-eosin cross sections. Immuno-(DAKO).
histochemical stains for endothelial cells and myo-
fibroblasts were negative. Extracellular matrix fibres
were observed in scanning electron micrographs, con-Fluorescence microscopy
firming that the endothelial cell layer was completely
removed. The remaining extracellular matrix thus con-Fresh samples of the aortic wall were taken 60 min
after endothelial cell seeding and gently washed sev- sisted of collagen and elastin fibres from the original
vessel.eral times with PBS. They were incubated with two
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Table 1. Patency at the time of explantation of decellularised endothelial cell seeded grafts (group I), PDS prosthesis of 4 mm (group
II) or 5 mm (group III) inner diameter, and carotidal autografts (group IV) after 1 week (a) and 4 months (b). Number of grafts (percent).
Table 1a.
Group Patent graft Patency stenosis Obstruction Total
I 1 (11%) 3 (33%) 5 (56%)∗ 9
II 0 2 (17%) 10 (83%) 12
III 0 4 (50%) 4 (50%) 8
IV 4 (100%) 0 0 4
p values: group I vs IV, p<0.01, II vs IV, p=0.001; III vs IV, p<0.01.
Table 1b.
Group Patent graft Patency stenosis Obstruction Total
I 3 (43%) 2 (29%) 2 (29%)∗ 7
II 0 0 6 (100%) 6
III 0 6 (50%) 6 (50%) 12
IV 4 (100%) 0 0 4
p values: group I vs II, p<0.05, II vs III, p<0.05; II vs IV, p<0.01; III vs IV, p<0.01.
∗ Includes animal, that received only one carotidal graft.
Fig. 1. Digital subtraction angiography shows patent carotid arteries grafted with autologous carotis (a), seeded acellular matrix grafts
(b), and occlusion of the right common carotid artery and significant stenosis of the left carotid artery after replacement with a PDS
prosthesis (c); right (1), left (1′) common carotid artery, brachiocephalic trunk (2), right subclavian artery (3), anastomotic sites (arrows).
Cell seeding graft surface. There was no penetration of any cell
type into the acellular matrix at this point of time. TheSeeding density was 180 000±60 000 cells/cm2. Micro-
scopic examination demonstrated factor VIII positive arteries remained macroscopically intact and mech-
anically stable with good handling conditions.endothelial cells on the surface of the segments 60 min
after static seeding of the acellular matrix and con-
secutive washing. Fluorescence microscopic ex- Morphology
At the time of explantation, artery segments of controlamination with EthD-1 and calcein-AM demonstrated
a predominance of attached viable cells. The seeding group IV revealed normal morphological features with
a normal endothelium and no signs of intimal hy-process did not lead to a fully confluent layer of
endothelial cells. Scanning electron microscopy in- perplasia. They macroscopically showed none or mild
adventitial reaction (Fig. 2).dicated both rounded and flat endothelial cells on the
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Fig. 2. Explanted carotid segments. Compared to autografts (a),
perivascular tissue reaction is increased in seeded acellular matrix
grafts (b), and PDS (c) 4 months after implantation. Bar indicates
1 cm.
The angiographic diagnosis of stenosis or ob-
struction in group II and III was confirmed by means
of histological examination, and they were caused by
thrombotic material after one week. The polymer fibres
were clearly visible and surrounded by a variety of
inflammatory cells, primarily macrophages (Fig. 3).
Stenosed and obstructed grafts showed signs of or-
ganised thrombus and intimal thickening. These issues
were merely indistinguishable. Macroscopically, ves-
sels were surrounded by large amounts of connective
tissue.
Seeded acellular matrix grafts were encapsulated
in host connective tissue with minor inflammatory
reaction. Elastic and collagen fibres were well pre-
served after one week and 4 months. Scanning electron
microscopy of patent grafts demonstrated a lumen
covered with a continuous endothelial cell-like lining
morphologically indistinguishable from that in au-
tologous controls and positive for von Willebrand
Fig. 3. Histological cross sections, 4 months after implantation, seefactor. Myofibroblasts were present in the new vessel
text; (a) patent carotid autograft (10×), (b) obstructed PDS prosthesiswall. We did not perform viability or function tests (40×), (c) patent seeded decellularised matrix graft (40×); adventitia
(A), organised thrombus (OT), polydioxanone fibres (PDS), lumenon the explanted grafts. Stenoses and obstructions
(L), elastic fibres (E).occurred in grafts with thrombus formation, intimal
thickening, or both. Calcification was absent.
represent a significant advance.15,25 Biodegradable sub-
stances such as polyglycolic acid or polydioxanoneDiscussion
have been tested both in vitro and in preclinical studies
with promising results.26,27 On the other hand, theThere is a pressing clinical need for better small calibre
vascular grafts.23,24 A tissue-engineered conduit, with induction of foreign body reaction and thrombus for-
mation by these biodegradable polymers, especially ifthe potential to remodel and to grow, made of
autologous cells and a biocompatible scaffold, would not completely degraded at the time of implantation,
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is well described in the literature.28 Both types of toration of the three dimensional structure of blood
vessels after tissue engineering implies the resorptionreaction were present in our animals of group I, II,
and regeneration of tissue exerted by the seeded cellsand III. Our results indicate the PDS prostheses are
or newly immigrating myofibroblasts. The presenceunsuitable as small calibre prosthetic grafts, at least
of all primary cell types of vessel tissue (endothelialin this porcine model.
cells and myofibroblasts) may be an important factorSeeded decellularised grafts4,29,30 showed superior
in the regulation of matrix synthesis by the secretionpatency rates to PDS. Patent grafts revealed confluent
of extracellular matrix products, cytokines, andendothelial lining and only a mild inflammatory re-
chemokines.34action comparable to carotid autografts. Patency may
The observation of tissue reconstruction in thebe related to the extent of endothelialisation prior to
seeded acellular grafts raises the question of cell dif-implantation or to cell retention on the decellularised
ferentiation. The immigration of cells into the in-matrix after in vivo perfusion.4,30 Incomplete coverage
terstitium and endothelial cell lining does not implyis related to higher thrombogenicity and may imply
a reconstitution of normal cell function in the re-higher obstruction rates.31 However, other workers
constructed blood vessel. Thickening of the vessel wallhave obtained impressive results with non-seeded
in histology indicates that proliferation and matrixacellularised grafts in sheep.13,18 On light and scanning
synthesis may overshoot at least in the first weekselectron examination the architecture of fibres is main-
after in vivo implantation (Fig. 2).tained after enzyme treatment. Histologic examination
In vivo studies have to show in longer time intervalsof decellularised carotid arteries revealed an extra-
(1 year) after transplantation the ultimate result ofcellular matrix consisting of well preserved, normally
viability of the tissue engineered vessel. Cell biologicalarranged collagen and elastin fibres.4 Due to the non-
studies have to compare the cell types of the tissueexistence of cellular antigens, especially foreign endo-
engineered vessel with normal arterial cells. This maythelial cell antigens, the immunological potential of
involve the expression of integrin receptors, activitythe resulting structure is low. This may prevent critical
of metalloproteinase receptors and their inhibitors.35inflammatory or immune reactions. Endothelial cell-
Moreover, cellular differentiation has to be shown byseeded allografts showed almost no inflammatory re-
means of molecular biology methods.action, and freedom from both calcification and
The use of seeded acellularised vessels from animalexcessive tissue overgrowth.16 The amount of in-
or human origin may provide good functional results.flammation may depend on the quality of cell seeding.
Different from biodegradable polymer scaffolds, avail-The implantation process itself can lead to a loss of
ability and physiological design of implants are not aattached endothelial cells especially in a gaft of only
problem, especially concerning small vessels and heart2 cm length (grasping with forceps, suturing). On the
valves. Modification of the currently used cryo-other hand, we were able to show that patent grafts
preservation of allograft tissue for transplantation towere merely distinguishable from native arterial seg-
a process of decellularisation may be discussed andments by means of histology and angiography (Figs
evaluated for improvement of current clinical results.1 and 3). Angiographic results suggest an ability to
However, the increase of thrombogenicity by the acel-remodel or grow, as no apparent differences in calibre
lularisation exposing collagen ligands to the throm-of natural arteries and grafts were seen in the patent
bocyte integrin receptors may be a major disadvantagedecellularised grafts (Fig. 1).
of an unmodified unseeded acellular conduit, whichResorption of the acellular matrix is important for
can be prevented by cell seeding or chemical im-three dimensional reorganisation and graft integration.
pregnation prior to implantation. Further studies haveThis requires the adhesion of endothelial cells, in vivo
to address these questions in detail before clinicalinvasion and ingrowth of smooth muscle cells and
studies can be performed.fibroblasts into the acellular matrix scaffold from the
adjacent tissue after implantation. This represents a
highly differentiated process, involving all surface re-
ceptors as integrins, regulation of extracellular matrix
protein synthesis, and degradation by metallo-
proteinases.32 Tenascin and fibronectin are important
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